Dr. J. Vijay Venkatraman, India Regional Editor for <a href="https://globalforum.diaglobal.org/" target="_blank">Global Forum </a>and Managing Director & CEO for Oviya MedSafe Private Limited (India), discusses the <a href="http://www.cdsco.nic.in/writereaddata/pharmacovigilanceGuidance.pdf" target="_blank">Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products in India</a>, which came into effect January 2018, and the Pharmacovigilance Programme of India (PvPI).

Dr. J. Vijay Venkatraman, India Regional Editor for Global Forum and Managing Director & CEO for Oviya MedSafe Private Limited (India), discusses the Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products in India, which came into effect January 2018, and the Pharmacovigilance Programme of India (PvPI).

Dr. J. Vijay Venkatraman, India Regional Editor for <a href="https://globalforum.diaglobal.org/" rel="noopener noreferrer">Global Forum </a>and Managing Director &amp; CEO for Oviya MedSafe Private Limited (India), discusses the <a href="http://www.cdsco.nic.in/writereaddata/pharmacovigilanceGuidance.pdf" rel="noopener noreferrer">Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products in India</a>, which came into effect January 2018, and the Pharmacovigilance Programme of India (PvPI).

PvPI: Technology Meets Opportunity to Improve Safety

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share PvPI: Technology Meets Opportunity to Improve Safety

Sign up to save your podcasts

PvPI: Technology Meets Opportunity to Improve Safety

PvPI: Technology Meets Opportunity to Improve Safety